Skip to main content

Cytolytic Vaginosis: a Critical Appraisal of a Controversial Condition

Abstract

Purpose of Review

Cytolytic vaginosis is a controversial condition that some clinicians have traditionally included as a potential cause of vulvovaginal symptoms despite the lack of scientific evidence.

Recent Findings

Recent articles have focused on the evaluation of patients once they carry the diagnosis of cytolytic vaginosis, rather than on diagnostic criteria.

Summary

Our review revealed inadequate criteria for excluding other causes of vulvovaginal symptoms, especially VVC, when diagnosing women with cytolytic vaginosis. Treatment recommendations have remained stagnant with no single case report or case series with detailed information about affected patients. Finally, with the inconsistencies in sampling sites and inadequacies in sampling techniques across studies, the reported evidence of lactobacilli overgrowth is unreliable and cannot be used to support the diagnosis of cytolytic vaginosis. Any future investigations of the condition would need to have strict criteria for diagnosis which can be reproduced by other investigators, so that common ground for diagnosis can begin as a basis for studies. We further recommend that any study evaluating patient treatments include information about patient demographics, details about their treatment, and the results in terms of changes in symptoms and findings.

This is a preview of subscription content, access via your institution.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Anderson MR, Klink K, Cohrssen A. Evaluation of vaginal complaints. Jama. 2004;291(11):1368–79.

    CAS  Article  Google Scholar 

  2. Vallor AC, Antonio MA, Hawes SE, Hillier SL. Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: role of hydrogen peroxide production. J Infect Dis. 2001;184(11):1431–6.

    CAS  Article  Google Scholar 

  3. Beigi RH, Wiesenfeld HC, Hillier SL, Straw T, Krohn MA. Factors associated with absence of H2O2-producing Lactobacillus among women with bacterial vaginosis. J Infect Dis. 2005;191(6):924–9.

    Article  Google Scholar 

  4. • Cibley LJ, Cibley LJ. Cytolytic vaginosis. Am J Obstet Gynecol. 1991;165(4 Pt 2):1245–9 This is the original cytolytic vaginosis article.

    CAS  Article  Google Scholar 

  5. Batashki I, Markova D, Milchev N. Frequency of cytolytic vaginosis--examination of 1152 patients. Akush Ginekol (Sofiia). 2009;48(5):15–6.

    CAS  Google Scholar 

  6. Demirezen S. Cytolytic vaginosis: examination of 2947 vaginal smears. Cent Eur J Public Health. 2003;11(1):23–4.

    CAS  PubMed  Google Scholar 

  7. Shopova E, Tiufekchieva E, Karag'ozov I, Koleva V. Cytolytic vaginosis--clinical and microbiological study. Akush Ginekol (Sofiia). 2006;45(Suppl 2):12–3.

    Google Scholar 

  8. • Yang S, Zhang Y, Liu Y, Wang J, Chen S, Li S. Clinical significance and characteristic clinical differences of cytolytic vaginosis in recurrent vulvovaginitis. Gynecol Obstet Investig. 2017;82(2):137–43 This study includes yeast culture in the diagnostic criteria for CV in patients with recurrent vulvovaginitis.

    CAS  Article  Google Scholar 

  9. Workowski KA, Bolan GA, Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1–137.

    PubMed  PubMed Central  Google Scholar 

  10. • Committee on Practice Bulletins—Gynecology. Vaginitis in nonpregnant patients: ACOG Practice Bulletin, Number 215. Obstet Gynecol. 2020;135(1):e1–e17 The ACOG Practice Bulletin on principles of vaginitis does not include cytolytic vaginosis as a potential cause of vaginitis.

    Article  Google Scholar 

  11. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 1985;152(7 Pt 2):924–35.

    CAS  Article  Google Scholar 

  12. Beghini J, Linhares IM, Giraldo PC, Ledger WJ, Witkin SS. Differential expression of lactic acid isomers, extracellular matrix metalloproteinase inducer, and matrix metalloproteinase-8 in vaginal fluid from women with vaginal disorders. BJOG. 2015;122(12):1580–5.

    CAS  Article  Google Scholar 

  13. Cerikcioglu N, Beksac MS. Cytolytic vaginosis: misdiagnosed as candidal vaginitis. Infect Dis Obstet Gynecol. 2004;12(1):13–6.

    Article  Google Scholar 

  14. Sanches JM, Giraldo PC, Amaral R, Eberlin MN, Marques LA, Migliorini I, et al. Vaginal lipidomics of women with vulvovaginal candidiasis and cytolytic vaginosis: a non-targeted LC-MS pilot study. PLoS One. 2018;13(8):e0202401.

    Article  Google Scholar 

  15. Hu Z, Zhou W, Mu L, Kuang L, Su M, Jiang Y. Identification of cytolytic vaginosis versus vulvovaginal candidiasis. J Low Genit Tract Dis. 2015;19(2):152–5.

    Article  Google Scholar 

  16. Xu H, Zhang X, Yao W, Sun Y, Zhang Y. Characterization of the vaginal microbiome during cytolytic vaginosis using high-throughput sequencing. J Clin Lab Anal. 2019;33(1):e22653.

    Article  Google Scholar 

  17. Churchman SA, Moss JA, Baum MM. Accurate measurement of female genital tract fluid dilution in cervicovaginal lavage samples. J Chromatogr B Anal Technol Biomed Life Sci. 2016;1017–1018:75–81.

    Article  Google Scholar 

  18. Dezzutti CS, Hendrix CW, Marrazzo JM, Pan Z, Wang L, Louissaint N, et al. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators. PLoS One. 2011;6(8):e23136.

    CAS  Article  Google Scholar 

  19. Mitchell C, Paul K, Agnew K, Gaussman R, Coombs RW, Hitti J. Estimating volume of cervicovaginal secretions in cervicovaginal lavage fluid collected for measurement of genital HIV-1 RNA levels in women. J Clin Microbiol. 2011;49(2):735–6.

    Article  Google Scholar 

  20. Azevedo S, Lima-Silva J, Vieira-Baptista P. Impact of the sampling site in the result of wet mount microscopy. J Low Genit Tract Dis. 2019;23(2):176–81.

    Article  Google Scholar 

  21. Bercovici B, Schechter A, Golan J. Cytolysis in normal and complicated pregnancy. Am J Obstet Gynecol. 1973;116(6):831–4.

    CAS  Article  Google Scholar 

  22. Lustig G, Ryan CM, Secor WE, Johnson PJ. Trichomonas vaginalis contact-dependent cytolysis of epithelial cells. Infect Immun. 2013;81(5):1411–9.

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Malia Voytik.

Ethics declarations

Conflict of Interest

Malia Voytik has no conflicts of interest to disclose. Paul Nyirjesy has received research funds from the Curatek Pharmaceuticals, Mycovia Pharmaceuticals, and Scynexis, Inc. and has served as a consultant for the Mycovia Pharmaceuticals, Hologic Corporation, Lupin Pharmaceuticals, Hologic, Inc., Scynexis, Inc., Daré Bioscience, Inc., and Becton, Dickinson.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Female Genital Tract Infections

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Voytik, M., Nyirjesy, P. Cytolytic Vaginosis: a Critical Appraisal of a Controversial Condition. Curr Infect Dis Rep 22, 26 (2020). https://doi.org/10.1007/s11908-020-00735-w

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11908-020-00735-w

Keywords

  • Cytolytic vaginosis
  • Vaginitis
  • Vaginal discharge